BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

850 related articles for article (PubMed ID: 26300000)

  • 1. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
    Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
    Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic targeting of splicing in cancer.
    Lee SC; Abdel-Wahab O
    Nat Med; 2016 Sep; 22(9):976-86. PubMed ID: 27603132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing Factor Mutations in Cancer.
    Bejar R
    Adv Exp Med Biol; 2016; 907():215-28. PubMed ID: 27256388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Splicing Dysregulation as Oncogenic Driver and Passenger Factor in Brain Tumors.
    Bielli P; Pagliarini V; Pieraccioli M; Caggiano C; Sette C
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic Mutational Landscape of Splicing Factor Genes and Their Functional Consequences across 33 Cancer Types.
    Seiler M; Peng S; Agrawal AA; Palacino J; Teng T; Zhu P; Smith PG; ; Buonamici S; Yu L
    Cell Rep; 2018 Apr; 23(1):282-296.e4. PubMed ID: 29617667
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the aberrant splicing of MAP3K7 induced by cancer-associated SF3B1 mutation.
    Li Z; Zhao B; Shi Y; Liang Y; Qian R; Wan Y
    J Biochem; 2021 Sep; 170(1):69-77. PubMed ID: 33751071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Splicing-factor alterations in cancers.
    Anczuków O; Krainer AR
    RNA; 2016 Sep; 22(9):1285-301. PubMed ID: 27530828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale analysis of genome and transcriptome alterations in multiple tumors unveils novel cancer-relevant splicing networks.
    Sebestyén E; Singh B; Miñana B; Pagès A; Mateo F; Pujana MA; Valcárcel J; Eyras E
    Genome Res; 2016 Jun; 26(6):732-44. PubMed ID: 27197215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of alternative splicing in cancer: From oncogenesis to drug resistance.
    Sciarrillo R; Wojtuszkiewicz A; Assaraf YG; Jansen G; Kaspers GJL; Giovannetti E; Cloos J
    Drug Resist Updat; 2020 Dec; 53():100728. PubMed ID: 33070093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutational landscape of RNA-binding proteins in human cancers.
    Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
    RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting splicing abnormalities in cancer.
    Agrawal AA; Yu L; Smith PG; Buonamici S
    Curr Opin Genet Dev; 2018 Feb; 48():67-74. PubMed ID: 29136527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA Splicing and Cancer.
    Wang E; Aifantis I
    Trends Cancer; 2020 Aug; 6(8):631-644. PubMed ID: 32434734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic Targeting of RNA Splicing in Cancer.
    Bonner EA; Lee SC
    Genes (Basel); 2023 Jun; 14(7):. PubMed ID: 37510283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathways: Understanding and Targeting Mutant Spliceosomal Proteins.
    Yoshimi A; Abdel-Wahab O
    Clin Cancer Res; 2017 Jan; 23(2):336-341. PubMed ID: 27836865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hematological malignancies driven by aberrant splicing].
    Zang W; Saika W; Aoyama Y; Inoue D
    Rinsho Ketsueki; 2023; 64(9):875-883. PubMed ID: 37793861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of RNA Splicing: Aberrant Splicing Regulation and Therapeutic Targets in Cancer.
    Kitamura K; Nimura K
    Cells; 2021 Apr; 10(4):. PubMed ID: 33923658
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing and cancer: a systematic review.
    Zhang Y; Qian J; Gu C; Yang Y
    Signal Transduct Target Ther; 2021 Feb; 6(1):78. PubMed ID: 33623018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RNA splicing, cell signaling, and response to therapies.
    Abou Faycal C; Gazzeri S; Eymin B
    Curr Opin Oncol; 2016 Jan; 28(1):58-64. PubMed ID: 26575690
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splicing dysregulation in cancer: from mechanistic understanding to a new class of therapeutic targets.
    Wang Y; Bao Y; Zhang S; Wang Z
    Sci China Life Sci; 2020 Apr; 63(4):469-484. PubMed ID: 32086672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysregulation and therapeutic targeting of RNA splicing in cancer.
    Stanley RF; Abdel-Wahab O
    Nat Cancer; 2022 May; 3(5):536-546. PubMed ID: 35624337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 43.